207 related articles for article (PubMed ID: 26474267)
1. Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness.
Busani S; Damiani E; Cavazzuti I; Donati A; Girardis M
Minerva Anestesiol; 2016 May; 82(5):559-72. PubMed ID: 26474267
[TBL] [Abstract][Full Text] [Related]
2. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
Laupland KB; Kirkpatrick AW; Delaney A
Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
[TBL] [Abstract][Full Text] [Related]
3. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock.
Kreymann KG; de Heer G; Nierhaus A; Kluge S
Crit Care Med; 2007 Dec; 35(12):2677-85. PubMed ID: 18074464
[TBL] [Abstract][Full Text] [Related]
4. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
[TBL] [Abstract][Full Text] [Related]
5. To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock.
Neugebauer EA
Crit Care Med; 2007 Dec; 35(12):2855-6. PubMed ID: 18043203
[No Abstract] [Full Text] [Related]
6. Mirror, mirror on the wall, which is the fairest meta-analysis of all?
Werdan K
Crit Care Med; 2007 Dec; 35(12):2852-4. PubMed ID: 18043202
[No Abstract] [Full Text] [Related]
7. Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis.
Turgeon AF; Hutton B; Fergusson DA; McIntyre L; Tinmouth AA; Cameron DW; Hébert PC
Ann Intern Med; 2007 Feb; 146(3):193-203. PubMed ID: 17283351
[TBL] [Abstract][Full Text] [Related]
8. The use of IgM-enriched immunoglobulin in adult patients with sepsis.
Kakoullis L; Pantzaris ND; Platanaki C; Lagadinou M; Papachristodoulou E; Velissaris D
J Crit Care; 2018 Oct; 47():30-35. PubMed ID: 29886064
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin for treating sepsis and septic shock.
Alejandria MM; Lansang MA; Dans LF; Mantaring JB
Cochrane Database Syst Rev; 2001; (2):CD001090. PubMed ID: 11405973
[TBL] [Abstract][Full Text] [Related]
10. Polyclonal intravenous immunoglobulin: an important additional strategy in sepsis?
Di Rosa R; Pietrosanti M; Luzi G; Salemi S; D'Amelio R
Eur J Intern Med; 2014 Jul; 25(6):511-6. PubMed ID: 24877856
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials.
Xu JY; Chen QH; Xie JF; Pan C; Liu SQ; Huang LW; Yang CS; Liu L; Huang YZ; Guo FM; Yang Y; Qiu HB
Crit Care; 2014 Dec; 18(6):702. PubMed ID: 25499187
[TBL] [Abstract][Full Text] [Related]
13. Early Goal-Directed Therapy in Severe Sepsis and Septic Shock: A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials.
Lu Y; Zhang H; Teng F; Xia WJ; Sun GX; Wen AQ
J Intensive Care Med; 2018 May; 33(5):296-309. PubMed ID: 27756870
[TBL] [Abstract][Full Text] [Related]
14. Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis.
Norrby-Teglund A; Haque KN; Hammarström L
J Intern Med; 2006 Dec; 260(6):509-16. PubMed ID: 17116001
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Early Goal-Directed Therapy on Outcome in Adult Severe Sepsis and Septic Shock Patients: A Meta-Analysis of Randomized Clinical Trials.
Xu JY; Chen QH; Liu SQ; Pan C; Xu XP; Han JB; Xie JF; Huang YZ; Guo FM; Yang Y; Qiu HB
Anesth Analg; 2016 Aug; 123(2):371-81. PubMed ID: 27049857
[TBL] [Abstract][Full Text] [Related]
16. Use of Intravenous Immunoglobulins in Sepsis Therapy-A Clinical View.
Jarczak D; Kluge S; Nierhaus A
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32756325
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin for treating sepsis and septic shock.
Alejandria MM; Lansang MA; Dans LF; Mantaring JB
Cochrane Database Syst Rev; 2000; (2):CD001090. PubMed ID: 10796589
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of immunoglobulin M-enriched immunoglobulin (Pentaglobin) in the treatment of severe sepsis and septic shock.
Neilson AR; Burchardi H; Schneider H
J Crit Care; 2005 Sep; 20(3):239-49. PubMed ID: 16253792
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin treatment in sepsis--is the answer "no"?
Werdan K
Crit Care Med; 2006 May; 34(5):1542-4. PubMed ID: 16633249
[No Abstract] [Full Text] [Related]
20. Pathophysiology of septic shock and multiple organ dysfunction syndrome and various therapeutic approaches with special emphasis on immunoglobulins.
Werdan K
Ther Apher; 2001 Apr; 5(2):115-22. PubMed ID: 11354295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
